$BDRL
BLONDER TONGUE LABORATORIES INC

2015 Q2 Form 10-Q Financial Statement

#000114420415049290 Filed on August 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $5.283M $8.828M
YoY Change -40.16% 23.54%
Cost Of Revenue $3.747M $5.353M
YoY Change -30.0% 14.04%
Gross Profit $1.536M $3.475M
YoY Change -55.8% 41.72%
Gross Profit Margin 29.07% 39.36%
Selling, General & Admin $1.800M $2.133M
YoY Change -15.61% -3.0%
% of Gross Profit 117.19% 61.38%
Research & Development $925.0K $929.0K
YoY Change -0.43% 11.12%
% of Gross Profit 60.22% 26.73%
Depreciation & Amortization $300.0K $350.0K
YoY Change -14.29% 9.38%
% of Gross Profit 19.53% 10.07%
Operating Expenses $2.724M $3.062M
YoY Change -11.04% 0.89%
Operating Profit -$1.188M $413.0K
YoY Change -387.65% -170.84%
Interest Expense $74.00K $66.00K
YoY Change 12.12% -14.29%
% of Operating Profit 15.98%
Other Income/Expense, Net
YoY Change
Pretax Income -$1.262M $347.0K
YoY Change -463.69% -152.58%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.262M $347.0K
YoY Change -463.69% -152.58%
Net Earnings / Revenue -23.89% 3.93%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.20 $0.06
COMMON SHARES
Basic Shares Outstanding 6.263M shares 6.216M shares
Diluted Shares Outstanding 6.263M shares 6.240M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.00K $50.00K
YoY Change -40.0% -70.59%
Cash & Equivalents $49.00K
Short-Term Investments
Other Short-Term Assets $360.0K $980.0K
YoY Change -63.27% 6.52%
Inventory $8.520M $8.437M
Prepaid Expenses
Receivables $2.260M $4.517M
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.16M $13.99M
YoY Change -20.21% -2.34%
LONG-TERM ASSETS
Property, Plant & Equipment $3.850M $3.975M
YoY Change -3.14% 3.17%
Goodwill $493.0K
YoY Change 0.0%
Intangibles $730.0K
YoY Change 25.86%
Long-Term Investments
YoY Change
Other Assets $2.240M $143.0K
YoY Change 1466.43% -19.21%
Total Long-Term Assets $9.233M $9.239M
YoY Change -0.06% -6.07%
TOTAL ASSETS
Total Short-Term Assets $11.16M $13.99M
Total Long-Term Assets $9.233M $9.239M
Total Assets $20.39M $23.23M
YoY Change -12.2% -3.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.700M $2.320M
YoY Change -26.72% 75.76%
Accrued Expenses $810.0K $650.0K
YoY Change 24.62% -48.82%
Deferred Revenue
YoY Change
Short-Term Debt $2.850M $1.790M
YoY Change 59.22% 12.58%
Long-Term Debt Due $3.740M $3.970M
YoY Change -5.79% 1333.21%
Total Short-Term Liabilities $9.120M $8.747M
YoY Change 4.26% 95.07%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $76.00K
YoY Change -86.84% -98.11%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.00K $76.00K
YoY Change -86.84% -98.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.120M $8.747M
Total Long-Term Liabilities $10.00K $76.00K
Total Liabilities $9.230M $8.823M
YoY Change 4.61% 3.69%
SHAREHOLDERS EQUITY
Retained Earnings -$4.008M
YoY Change 164.73%
Common Stock $26.32M
YoY Change 1.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.308M
YoY Change 0.0%
Treasury Stock Shares 2.248M shares
Shareholders Equity $11.17M $14.34M
YoY Change
Total Liabilities & Shareholders Equity $20.39M $23.23M
YoY Change -12.2% -3.86%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$1.262M $347.0K
YoY Change -463.69% -152.58%
Depreciation, Depletion And Amortization $300.0K $350.0K
YoY Change -14.29% 9.38%
Cash From Operating Activities -$670.0K -$10.00K
YoY Change 6600.0% -101.96%
INVESTING ACTIVITIES
Capital Expenditures $490.0K $550.0K
YoY Change -10.91% 189.47%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$490.0K -$550.0K
YoY Change -10.91% 189.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.080M 490.0K
YoY Change 120.41% -322.73%
NET CHANGE
Cash From Operating Activities -670.0K -10.00K
Cash From Investing Activities -490.0K -550.0K
Cash From Financing Activities 1.080M 490.0K
Net Change In Cash -80.00K -70.00K
YoY Change 14.29% -170.0%
FREE CASH FLOW
Cash From Operating Activities -$670.0K -$10.00K
Capital Expenditures $490.0K $550.0K
Free Cash Flow -$1.160M -$560.0K
YoY Change 107.14% -275.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Expenses
OperatingExpenses
5932000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2677000 USD
us-gaap Net Income Loss
NetIncomeLoss
-814000 USD
us-gaap Depreciation
Depreciation
220000 USD
us-gaap Depreciation
Depreciation
243000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
498000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
404000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
126000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
107000 USD
us-gaap Inventory Write Down
InventoryWriteDown
69000 USD
us-gaap Inventory Write Down
InventoryWriteDown
18000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1246000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-150000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-775000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-160000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
111000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-292000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
23000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
879000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
282000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
382000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1029000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
485000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9174000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
7109000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49000 USD
us-gaap Interest Paid
InterestPaid
122000 USD
us-gaap Interest Paid
InterestPaid
141000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8828000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5283000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
171000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-794000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-615000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
122000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
141000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
516000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1578000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
394000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1437000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-207000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5353000 USD
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3747000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
3475000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
1536000 USD
CY2014Q2 us-gaap Selling Expense
SellingExpense
881000 USD
CY2015Q2 us-gaap Selling Expense
SellingExpense
773000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
413000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1188000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
66000 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
74000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
347000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1262000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
347000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-1262000 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
14406000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10025000 USD
us-gaap Gross Profit
GrossProfit
5232000 USD
us-gaap Gross Profit
GrossProfit
2916000 USD
us-gaap Selling Expense
SellingExpense
1693000 USD
us-gaap Selling Expense
SellingExpense
1616000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2470000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2082000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1769000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1729000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
13683000 USD
CY2014Q4 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4426000 USD
us-gaap Interest Expense
InterestExpense
166000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-814000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2677000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1828000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1208000 shares
CY2015Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
5219000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5151000 USD
CY2015Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2260000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3045000 USD
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5663000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5487000 USD
CY2015Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2435000 USD
CY2014Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2798000 USD
CY2014 bdr Percentage Of Fifo Inventory Non Current For Finished Goods
PercentageOfFifoInventoryNonCurrentForFinishedGoods
0.66 pure
bdr Percentage Of Fifo Inventory Non Current For Finished Goods
PercentageOfFifoInventoryNonCurrentForFinishedGoods
0.63 pure
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
BLONDER TONGUE LABORATORIES INC
dei Entity Central Index Key
EntityCentralIndexKey
0001000683
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
BDR
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6262736 shares
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20393000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21244000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
191000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
176000 USD
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1963000 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1967000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6263000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6263000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6240000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6263000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6216000 shares
CY2015Q2 us-gaap Inventory Gross
InventoryGross
13142000 USD
CY2015Q2 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4625000 USD
CY2015Q2 us-gaap Assets
Assets
20393000 USD
CY2014Q4 us-gaap Assets
Assets
21244000 USD
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2202000 shares
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
2724000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
3062000 USD
us-gaap Operating Expenses
OperatingExpenses
5427000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-30000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
444000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
309000 USD
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6263000 shares

Files In Submission

Name View Source Status
0001144204-15-049290-index-headers.html Edgar Link pending
0001144204-15-049290-index.html Edgar Link pending
0001144204-15-049290.txt Edgar Link pending
0001144204-15-049290-xbrl.zip Edgar Link pending
bdr-20150630.xml Edgar Link completed
bdr-20150630.xsd Edgar Link pending
bdr-20150630_cal.xml Edgar Link unprocessable
bdr-20150630_def.xml Edgar Link unprocessable
bdr-20150630_lab.xml Edgar Link unprocessable
bdr-20150630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v417427_10q.htm Edgar Link pending
v417427_ex10-2.htm Edgar Link pending
v417427_ex31-1.htm Edgar Link pending
v417427_ex31-2.htm Edgar Link pending
v417427_ex32-1.htm Edgar Link pending